Sze Ting Lee

Loading... 2 0 20 0 false
Credit Name
Sze Ting Lee
Full Name
Lee, Sze Ting
 
 
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Hofman, Michael S

Results 1-6 of 6 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
1Jan-2024Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.Hofman, Michael S; Emmett, Louise; Sandhu, Shahneen; Iravani, Amir; Buteau, James P; Joshua, Anthony M; Goh, Jeffrey C; Pattison, David A; Tan, Thean Hsiang; Kirkwood, Ian D; Ng, Siobhan; Francis, Roslyn J; Gedye, Craig; Rutherford, Natalie K; Weickhardt, Andrew J ; Scott, Andrew M ; Lee, Sze Ting ; Kwan, Edmond M; Azad, Arun A; Ramdave, Shakher; Redfern, Andrew D; Macdonald, William; Guminski, Alex; Hsiao, Edward; Chua, Wei; Lin, Peter; Zhang, Alison Yan; Stockler, Martin R; Williams, Scott G; Martin, Andrew J; Davis, Ian D
26-Dec-2023Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer.Buteau, James P; Moon, Daniel; Fahey, Michael T; Roberts, Matthew J; Thompson, James; Murphy, Declan G; Papa, Nathan; Mitchell, Catherine; De Abreu Lourenco, Richard; Dhillon, Haryana M; Kasivisvanathan, Veeru; Francis, Roslyn J; Stricker, Phillip; Agrawal, Shihka; O'Brien, Jonathan; McVey, Aoife ; Sharma, Gaurav; Levy, Sidney; Ayati, Narjess ; Nguyen, Andrew; Lee, Su-Faye; Pattison, David A; Sivaratnam, Dinesh; Frydenberg, Mark; Du, Yang; Titus, Jehan; Lee, Sze Ting ; Ischia, Joseph J ; Jack, Greg; Hofman, Michael S; Emmett, Louise
3Nov-2022PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.Buteau, James P; Martin, Andrew J; Emmett, Louise; Iravani, Amir; Sandhu, Shahneen; Joshua, Anthony M; Francis, Roslyn J; Zhang, Alison Y; Scott, Andrew M ; Lee, Sze Ting ; Azad, Arun A; McJannett, Margaret M; Stockler, Martin R; Williams, Scott G; Davis, Ian D; Hofman, Michael S
4Jun-2022The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective.Lee, Sze Ting ; Emmett, Louise M; Pattison, David A; Hofman, Michael S; Bailey, Dale L; Latter, Melissa J; Francis, Roslyn J; Scott, Andrew M 
527-Feb-2021[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.Hofman, Michael S; Emmett, Louise; Sandhu, Shahneen; Iravani, Amir; Joshua, Anthony M; Goh, Jeffrey C; Pattison, David A; Tan, Thean Hsiang; Kirkwood, Ian D; Ng, Siobhan; Francis, Roslyn J; Gedye, Craig; Rutherford, Natalie K; Weickhardt, Andrew J ; Scott, Andrew M ; Lee, Sze Ting ; Kwan, Edmond M; Azad, Arun A; Ramdave, Shakher; Redfern, Andrew D; Macdonald, William; Guminski, Alex; Hsiao, Edward; Chua, Wei; Lin, Peter; Zhang, Alison Y; McJannett, Margaret M; Stockler, Martin R; Violet, John A; Williams, Scott G; Martin, Andrew J; Davis, Ian D
62020Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study.Hofman, Michael S; Lawrentschuk, Nathan; Francis, Roslyn J; Tang, Colin; Vela, Ian; Thomas, Paul; Rutherford, Natalie; Martin, Jarad M; Frydenberg, Mark; Shakher, Ramdave; Wong, Lih-Ming ; Taubman, Kim; Lee, Sze Ting ; Hsiao, Edward; Roach, Paul; Nottage, Michelle; Kirkwood, Ian; Hayne, Dickon; Link, Emma; Marusic, Petra; Matera, Anetta; Herschtal, Alan; Iravani, Amir; Hicks, Rodney J; Williams, Scott; Murphy, Declan G